Chris Burns, CEO of Amplia Therapeutics, shared promising updates with Steve Darling from Proactive regarding the company’s ongoing Phase 2a clinical trial focused on treating advanced pancreatic cancer.
#Ampliatherapeutics #cancertreatment #cancerresearch #invest #investing #stockmarket #stocks #stockmarketnews
Ещё видео!